Royalty Pharma plcRPRXNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank52
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P52
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -25.68% |
| Q3 2025 | 855.12% |
| Q2 2025 | -87.34% |
| Q1 2025 | 14.47% |
| Q4 2024 | -61.72% |
| Q3 2024 | 433.30% |
| Q2 2024 | 2034.87% |
| Q1 2024 | -99.03% |
| Q4 2023 | 585.50% |
| Q3 2023 | -68.32% |
| Q2 2023 | -33.20% |
| Q1 2023 | 174.71% |
| Q4 2022 | -419.72% |
| Q3 2022 | -53.15% |
| Q2 2022 | 488.29% |
| Q1 2022 | 554.87% |
| Q4 2021 | -92.25% |
| Q3 2021 | -76.88% |
| Q2 2021 | 537.71% |
| Q1 2021 | -59.60% |
| Q4 2020 | -41.13% |
| Q3 2020 | -34.26% |
| Q2 2020 | 520.54% |
| Q1 2020 | -94.98% |
| Q4 2019 | 247.30% |
| Q3 2019 | 169.58% |
| Q2 2019 | -58.71% |
| Q1 2019 | 0.00% |